Add-On Pembrolizumab Misses in Locally Advanced Head and Neck Cancer
(MedPage Today) -- PARIS -- Combining a PD-1 inhibitor with standard chemoradiotherapy (CRT) failed to significantly improve survival outcomes in unresectable locally advanced head and neck squamous cell carcinoma, results of the phase III KEYNOTE...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | Hematology | HNSCC | Skin Cancer | Squamous Cell Carcinoma